Resources from the same session
ESMO COLLOQUIUM - Are biosimilars the key to access, in practice? - Introduction
Presenter: E.G. Elisabeth de Vries
Session: ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?
Resources:
Slides
Webcast
Existing challenges for uptake of oncology biosimilars – ESMO survey results
Presenter: Malvika Vyas
Session: ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?
Resources:
Slides
Webcast
In practice (UK): patients being switched from a biologic to a biosimilar - UK
Presenter: Stephen Scowcroft
Session: ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?
Resources:
Slides
Webcast
One year on – state of play in the EU on oncology biosimilars
Presenter: Murray Aitken
Session: ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?
Resources:
Slides
Webcast
Supplementary Protection Certificates & their potential impact on availability of biosimilars
Presenter: Roberto Romandini
Session: ESMO COLLOQUIUM - Are biosimilars the key to access, in practice?